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The effect of polyethylene glycol (PEG) coating on the magneto-structural properties and 
colloidal stability of Co0.8Mg0.2Fe2O4 magnetic nanoparticles (MNPs) was studied with 
their potential biomedical applications in mind using powder X-ray diffraction (XRD), 
Field Emission Scanning Electron Microscope (FESEM), vibrating sample magnetometer 
(VSM) and zeta potential measurements. Co0.8Mg0.2Fe2 MNPs were synthesized by a two-
step chemical method including solution combustion synthesis followed by 
functionalisation with PEG. The XRD patterns indicate that the crystalline single phase 
cubic spinel structure was retained after PEG coating. Also, after PEG coating, the 
crystallite size (from Scherrer formula) increases from 50 to 56 nm. Magnetic 
measurements of both coated and uncoated particles reveal the ferrimagnetic nature at 
room temperature with the PEG coated sample recording a higher magnetic moment. The 
resulting PEG coated particles form a more stable suspension in aqueous environment and 
also an appreciable stability in phosphate buffer solution (PBS) at physiological pH. The 
higher magnetization and colloidal stability recorded with PEG coatings is an important 
parameter in biomedical applications.  
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1. Introduction 
 
Nanotechnology is a frontier in science, engineering and manufacturing which has 
introduced new opportunities for the improvement of medical treatment. The application of 
nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered 
materials at the molecular scale to develop novel therapeutic and diagnostic devices generally 
encompassing 1–500 nm [1-3]. Magnetic nanoparticles (MNPs) are one of the important sub-
classes of nanomaterials applied in cancer diagnosis and therapy [4]. In the past few years, MNPs 
have been mainly used as heat sources in the treatment of tumors by hyperthermia and as 
nanovectors for controlled drug delivery [5,6]. 
Ferrite nanoparticles are well suited for biomedical applications because their sizes can be 
manipulated and also their surface can be functionalised with appropriate molecules to make them 
highly selective towards their targets [7,8]. The use of iron oxide (magnetite) nanoparticles such as 
Fe3O4 and substituted iron oxides (MFe2O4 where M = Co, Mn, Zn, Mg etc.) for biomedical 
applications has been studied extensively [9].Superparamagnetic iron oxide nanoparticles have 
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been the most appealing because of their biocompatibility, enhanced specific loss power and easy 
functionalisation. However, it has been found that in most recent clinical trials of local 
hyperthermia, for example, a large dose (milligram-level) of these nanoparticles are required to be 
injected into the tumour due to the low energy conversion efficiency of such ultra-small MNPs 
[10]. Hence, the selection of the most advantageous materials for clinical hyperthermia treatment, 
as well as other biomedical applications, is still a matter of debate [11]. One strategy used in the 
design of magnetic core for biomedical applications is the synthesis of mixed ferrites, where 
simple ferrites with one type of magnetic ion (excluding iron) are doped with other kinds of ion. 
This is done to utilise the different outstanding features of different ions [12]. Here, 20% of 
magnesium ions were used to dope cobalt ferrite for the exploitation of its potentials in magnetic 
hyperthermia. Cobalt ferrite (CoFe2O4) nanoparticles have a high saturation magnetization and 
magnetic anisotropy which improves the heat transfer rate. In biomedical applications, these are 
the properties desired when MNPs are to be used as heating mediators in hyperthermia treatments 
and as drug carriers since they can be easily manipulated by an applied magnetic field. And 
MgFe2O4 nanoparticles have been shown to be toxic towards cancer cells [13].  
Nanoparticles have hydrophobic surfaces with large surface to volume ratio hence the 
particles get agglomerated and form clusters that can easily adsorb plasma proteins. So, to prevent 
opsonisation and avoid macrophage recognition leading to the clearance of the MNPs, surface 
coating of the MNPs is required. The coating can consist of long-chain organic ligands or 
inorganic/organic polymers, where these ligands or polymers can be introduced during (in-situ 
coating) or after (post-synthetic coating) synthesis. PEG coated MNPs reveal excellent stability 
and solubility in aqueous dispersions and in physiological media [14]. PEG coatings have been 
used to reduce phagocytic capture of nanoparticles by the immune system, which can extend 
nanoparticle circulation time and subsequent accumulation in targeted tissue [15].PEG shell does 
not seem to affect the thermal characteristics and might make the magnetic fluid useful for 
hyperthermia treatment [16]. 
All biomedical applications of MNPs require that the nanoparticles have high 
magnetization values, with sizes smaller than 100 nm, and a narrow particle size distribution [17] 
which are all highly sensitive to synthesis methods. There are different methods of synthesis of 
ferrites which includes chemical co-precipitation and combustion methods. Although, chemical 
co-precipitation method is suitable for mass production of MNPs, it does require careful 
adjustment of pH. Combustion method is known for its cost effectiveness, low reaction time, large 
mass production and homogeneity among the products [18]. Also, no further thermal treatment is 
required for samples prepared by combustion method [19]. Therefore, the current study is about 
the solution combustion synthesis of nanocrystalline Co0.8Mg0.2Fe2O4 using glycine-nitrate mixture 
precursors which was subsequently stabilized with PEG. Since the coating of polymers on the 
surface of MNPs can alter some important properties of the particles, the effect of PEG coatings on 
the structural, morphological and magnetic properties are discussed in detail. The colloidal 
stability of bare and PEG coated Co0.8Mg0.2Fe2O4MNPs in water was examined. The colloidal 
stability of PEG coated Co0.8Mg0.2Fe2O4MNPs in phosphate buffer solution (PBS) at pH 7.4 
(physiological pH) and pH 5.0 (cancer cell endosomal pH) was also studied to highlight its 
stability in different physiological media. 
 
 
2. Experimental 
 
2.1 Materials  
Analytical gradeCo(NO3)2.6H2O (99 % purity of Sigma-Aldrich), Mg(NO3).6H2O (99% 
purity of Alfar Aesar), Fe(NO3)3.9H2O (99% purity of Sigma Aldrich)were taken as oxidants, 
while glycine (G, C2H5NO2) obtained from SD Fine Chem. Ltd., Mumbai, was employed as fuel to 
drive the combustion process. Polyethylene glycol (PEG-6000, MW: 5000-7000) obtained from 
Spectrochem, India was used for the surface coating of nanoparticles. Double distilled water was 
used throughout the experiments. All reagents were used without further purification. 
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2.2 Synthesis of Co0.8Mg0.2Fe2O4MNPs 
Co0.8Mg0.2Fe2O4MNPs were prepared by the solution combustion method using fuel rich 
glycine-nitrate (G/N = 2.22) composition. The optimization of the crystallinity and particle size of 
Co0.8Mg0.2Fe2O4MNPs using fuel to oxidizer ratio and sintering temperature has been studied in 
detail in our recent publication [20]. Appropriate amounts of Co(NO3)2.6H2O, Mg(NO3).6H2O, 
Fe(NO3)3.9H2O, and C2H5NO2were dissolved in 20 ml of de-ionised water. Then the solutions 
were heated to 80
o
C to form a viscuous gel of precursors under magnetic stirring. Secondly, the 
gel was transferred to a pre-heated coil (300
o
C). Finally, after a short moment, the solution 
precursors boiled, swelled, evolved a large amount of gases and ignited, followed by the yielding 
of puffy black products. The auto-combusted powder was used further for PEG coating without 
any subsequent annealing process.  
 
2.3 Synthesis of PEG Coated Co0.8Mg0.2Fe2O4 MNPs  
The MNPs were coated with PEG following the method [21] but with some modifications. 
Aqueous PEG solution (2% w/v) was prepared. The mixture of 100 mg Co0.8Mg0.2Fe2O4MNPs and 
distilled water (100 mL) were homogenized by ultrasonication for 30 min.Then the aqueous 
solution of PEG was added to the suspension of Co0.8Mg0.2Fe2O4 in water with slow agitation. 
After stirring for 24 hrs, the mixture of MNPs and PEG was washed three times with distilled 
water to remove excess PEG and then dried at 60
o
C for 1 hr. 
 
2.4 Characterization 
The X-ray diffractograms of the uncoated and PEG coated MNPs were recorded using an 
X-ray diffractometer (D8 Advance, Bruker, Germany), equipped with a Cu Kα radiation source (λ 
= 1.5406 A˚) and the crystallite size was calculated by the well-known Debye-Scherrer relation. 
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where β is the full-width at half maxima (in radians) of the strongest intensity diffraction peak 
(311), λ is the wavelength of the radiation and θ is the angle of the strongest characteristic peak. 
Eq. 2. was employed to calculate the lattice parameter (a) using the value of d-spacing of the 
strongest intensity diffraction peak. 
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where, h, k, l are the Miller indices of the crystal planes and dhkl is the separation of lattice planes 
X-ray density (Dx) wascalculated using equation 3. 
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Where, M is the molecular weight, N is the Avogadro’s number, and a, is the lattice 
constant. The surface morphology of the uncoated and PEG coated MNPswas examined with a 
Field Emission-Scanning Electron Microscopes, Nova Nano SEM 600 (FEI Co., Netherlands).The 
magnetic characterizations were carried out with a Vibrating Scanning Magnetometer (Lake Shore 
cryotronics-7400 series) under the applied field of ±20,000 G at room temperature. Zeta potential 
measurements were performed using a zeta sizer (Nano Zs, Nano series Malvern instruments). 
Measurements were taken in water and in PBS. Zeta potential measurements were done thrice for 
each sample at 30 electrode cycles.  
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3. Results and Discussion 
 
3.1 Coating of Co0.8Mg0.2Fe2O4 sample with PEG 
PEG was employed to coat theCo0.8Mg0.2Fe2O4 MNPs to improve its biocompatibility and 
colloidal stability for biological applications. PEG is a neutral, hydrophilic, linear synthetic 
polymer that shows excellent stability and solubility in aqueous dispersions and in physiological 
media. Fig. 1 shows a schematic representation of the coating of Co0.8Mg0.2Fe2O4 MNPs with 
PEG. 
 
 
 
3.2 Structural and Phase Analysis of PEG Coated Co0.8Mg0.2Fe2O4 MNPs 
The XRD patterns of PEG coated nanocrystalline Co0.8Mg0.2Fe2O4sample is shown in Fig. 
2. The effects of PEG coating on the structural properties ofCo0.8Mg0.2Fe2O4MNPs are presented in 
Table 1. Like the XRD of the uncoated sample, the diffraction peaks has the characteristic peaks of 
a single phase spinel cubic structure (JCPDS card no.22-1086). This clearly showed that the 
sample retained the spinel structure even after coating with PEG but with a suppression of 
diffraction peaks apparently due to the presence of PEG coatings. PEG can induce internal strain 
due to lattice mismatch i.e. lattice strain between polymer and MNPs at the interface which results 
readily in the decrease of the intensity of peaks [22]. There is a pronounced change in the 
calculated structural properties of coated sample compared to the uncoated sample with the coated 
sample recording higher values of all calculated structural properties than the uncoated sample. 
The calculated crystallite sizes (D) for uncoated and coated MNPs are 50 nm and 56 nm, 
respectively (Table 1). The increase in the calculated crystallite size which had also caused the 
increase in other structural properties might be due to the presence of PEG coating. It is likely that 
in the presence of PEG, small particles have tendency to join together and constitute large 
particles. The increase in crystallite size with polymer coating (PVA) has been reported for 
Ni0.3Zn0.7Fe2O4 MNPs [23]. 
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Fig. 2: X-ray diffraction patterns of (a) uncoated and (b) PEG coated Co0.8Mg0.2Fe2O4 MNPs 
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Table 1: Effects of PEG Coating on the Structural Properties of Co0.8Mg0.2Fe2O4 MNPs 
 
Co0.8Mg0.2Fe2O4 
MNPs 
Crystallite size, D, 
(nm) 
Lattice constant, a, 
(nm) 
Unit cell volume, 
V, nm
3
 
X-ray density, Dx, 
g/cm
3
 
Uncoated 50 0.838 0.589 5.140 
PEG coated 56 0.840 0.593 6.090 
 
 
3.3 Morphological Analysis of PEG Coated Co0.8Mg0.2Fe2O4 MNPs 
Fig. 3 shows typical FE-SEM images of uncoated and PEG coated Co0.8Mg0.2Fe2O4 MNPs. 
It can be seen from Fig. 3 that there is an enlargement of Co0.8Mg0.2Fe2O4 particles after PEG 
coating. Therefore, FE-SEM images confirm the XRD data regarding enlarging particles by PEG 
coating. As stated earlier, in the presence of PEG, small particles have tendency to join together 
and constitute large particles. Also, it can be observed from the FE-SEM images that the uncoated 
samples are in highly agglomerated form while the PEG coated sample displays much better 
dispersion. Enhancement in dispersibility after coating may be attributed to the presence of the 
non-magnetic surface layer of PEG which readily decreases the interparticle interaction. 
 
 
 
Fig. 3: FESEM images of Co0.8Mg0.2Fe2O4 samples (a) uncoated (b) PEG coated 
 
 
3.4 Magnetic Properties of PEG Coated Co0.8Mg0.2Fe2O4 MNPs 
The hysteresis loops measured at room temperature for the uncoated and PEG coated 
Co0.8Mg0.2Fe2O4 MNPs are shown in Fig. 4. The magnetic results show that Co0.8Mg0.2Fe2O4 MNPs 
(uncoated and PEG coated) is ferrimagnetic at room temperature. The saturation magnetization 
(Ms), remanence (Mr), coercivity (Hc) and loop squareness ratio (Mr/Ms) of the uncoated and 
coated sample are summarized in Table 2.The coated sample had a higher Ms, Mr and Hc but a 
lower Mr/Ms values than the uncoated sample. It can be seen that the Msof the coated sample (61 
emu/g) is higher than the uncoated sample (55 emu/g) at an applied field of ±20,000 G at 300 K. 
The increase in magnetization of the coated sample is probably due to the nanoparticles’ crystal 
growth (which is evident from the XRD result) after polymer coating. So the values of Ms are in 
accordance with the amount of magnetic substance in each material per gram. The increase in 
magnetization might be also due to spin injection or anti-spin canting being transpired at the 
surfaces of the MNPs due to the interaction with polymer chain [24]. Depending on the 
applications, certain properties of MNP are desired. In most biomedical applications, nanoparticles 
with higher saturation magnetization are preferred because they provide higher sensitivity and 
efficiency [25].  It can be seen that the PEG coatings conferred higher magnetization on the MNPs 
thereby enhancing their applications as heating foci in hyperthermia applications. The heating 
efficiency of hyperthermia nanomaterials obtained by measuring the specific loss power (SLP) is 
usually proportional to the Ms and Hc of the nanoparticles [26]. However, it is important to note 
that the heating efficiency of MNPs depends on many other factors such as particle size, shape, 
morphology as well as on extrinsic parameters like the applied AC magnetic field [27]. 
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Fig. 4: Magnetic hysteresis curves of Co0.8Mg0.2Fe2O4 (auto-combusted) measured  
at room temperature for (a) the uncoated sample (b) the PEG coated sample 
 
 
Table 2: Magnetic Properties of the Uncoated and the PEG Coated Co0.8Mg0.2Fe2O4 MNPs 
 
Sample Saturation 
Magnetisation, Ms 
       (emu/g) 
Remanence 
Magnetisation, Mr 
        (emu/g) 
Coercivity    
(Gauss) 
    Mr/ Ms 
Uncoated sample           55            30      1200       0.55 
PEG coated 
sample 
          61            33      1489       0.54 
 
  
3.5Colloidal Stability of PEG Coated Co0.8Mg0.2Fe2O4 MNPs 
The colloidal stability of the uncoated and PEG coated sample was evaluated by zeta 
potential measurements. The zeta potential distribution of uncoated and coated sample using 
distilled water as a dispersant is shown in Fig. 5. The zeta potential value in distilled water 
observed for the coated sample (-11.55 mV) is higher than the uncoated sample (-8.26 mV). This 
result shows that there is lesser aggregation of the coated sample in water compared to the 
uncoated sample. High charge differences (> ±10 mV) lead to greater interparticle repulsion [28] 
hence, there is enhancement of colloidal stability with increasing zeta potential values. Solubility 
in aqueous medium like water increases due to the hydrophilic ethylene glycol repeats in the PEG 
coating. Colloidal stability in aqueous as well as in physiological media like PBS is required for 
MNPs to be successfully applied in biomedical applications like magnetic fluid hyperthermia. The 
zeta potentials of the PEG coated sample is-14.00 mV at pH 7.4 (physiological pH) and -8.45 mV 
at pH 5.0 (cancer cell endosomal pH). At pH 7.4, more of the hydroxyl end groups will be ionized 
making it more negatively charged. At pH 5, the hydroxyl end group ionization is lesser thus 
lowering the net negative charge. The results show that the PEG coated Co0.8Mg0.2Fe2O4MNPs are 
relatively colloidally stable both in aqueous and physiological environments. These results imply 
that the PEG coated Co0.8Mg0.2Fe2O4 NPs could maintain their dispersion stability and heating 
capacity in various physiological environments and thus have great potentials to be used in 
biomedical applications. 
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Fig. 5: Zeta potential distribution of bare and PEG coated Co0.8Mg0.2Fe2O4 
nanoparticles using distilled water as dispersant 
 
 
4. Conclusion 
 
The single cubic spinel phase of nanocrystalline Co0.8Mg0.2Fe2O4 MNPs was obtained by 
the glycine mediated combustion synthesis with no further heat treatment. The surfaces of the 
synthesized MNPs were functionalized with PEG thereby conferring suitable chemical, physical 
and physiological properties for magnetic hyperthermia applications. From XRD, PEG coated 
sample retained their crystalline structure but with a slight suppression of peaks and crystallite size 
increased after coating. PEG coated Co0.8Mg0.2Fe2O4 MNPs recorded an increase in the structural 
and magnetic properties compared with the uncoated sample. The increase in structural properties 
was attributed to the tendency of small particles to join together and constitute large particles in 
the presence of PEG which also might have accounted for the increase in magnetic properties. 
There was improved colloidal stability with PEG coating in aqueous medium and also an 
appreciable stability in PBS at physiological pH highlighting the favourable potential biomedical 
applications of PEG coated Co0.8Mg0.2Fe2O4 MNPs. 
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